DepoCyt® (cytarabine liposome injection) is indicated for the intrathecal treatment of lymphomatous meningitis. DepoCyt is a cytotoxic anticancer drug and, as with other potentially toxic...

DepoCyt® (cytarabine liposome injection) is a sustained-release formulation of the active ingredient cytarabine designed for direct administration into the cerebrospinal fluid (CSF). Cytarabine...

DepoCyt ® (cytarabine liposome injection) is a sustained-release formulation of the active ingredient cytarabine designed for direct administration into the cerebrospinal fluid (CSF). Cytarabine is a cell cycle phase-specific antineoplastic agent, affecting cells only during the S-phase of cell division.

Mar 10, 2024 · Easy-to-read patient leaflet for DepoCyt. Includes indications, proper use, special instructions, precautions, and possible side effects.

COMMON BRAND NAME (S): DepoCyt. What should I tell my care team before I take this medication? They need to know if you have any of these conditions: •infection. •recent or ongoing radiation therapy. •an unusual or allergic reaction to cytarabine or ARA-C, other medicines, foods, dyes, or preservatives. •pregnant or trying to get pregnant.

Dec 13, 2021 · DepoCyt® (cytarabine liposome injection) is indicated for the intrathecal treatment of lymphomatous meningitis. DepoCyt is a cytotoxic anticancer drug and, as with other potentially toxic compounds, caution should be used in handling DepoCyt. The use of …

USES: Cytarabine liposome is a long-acting (sustained-release) chemotherapy drug used to treat cancer in the area around the spinal cord (lymphomatous meningitis). It works by slowing or stopping the growth of cancer cells. HOW TO USE: This medication is given by injection into the spinal fluid over 1 to 5 minutes by a health care professional.

Sep 6, 2017 · DepoCyt® (cytarabine liposome injection) is a sustained-release formulation of the active ingredient cytarabine designed for direct administration into the cerebrospinal fluid (CSF). Cytarabine is a cell cycle phase-specific antineoplastic agent, affecting cells only during the S-phase of cell division.

May 21, 2024 · Detailed drug Information for Depocyt. Includes common brand names, drug descriptions, warnings, side effects and dosing information.

Depocyt is indicated for the intrathecal treatment of lymphomatous meningitis. This indication is based on demonstration of increased complete response rate compared to unencapsulated cytarabine.